by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

ImmunityBio, Inc. Warning Letter Details

Warning Letter

ImmunityBio, Inc.

Recipient Title President and Chief Executive Officer, ImmunityBio, Inc., 9920 Jefferson Blvd Culver City , CA 90232 United States

Issue DateMarch 13, 2026

FEI NumberN/A

Violations2

CountryUnited States

Issuing Office

The Office of Prescription Drug Promotion (OPDP)

Product Type

Drugs

Status

Open

Subject

False & Misleading Claims/Misbranded

ImmunityBio, Inc. FDA Warning Letter, March 13, 2026